Aicardi-Goutieres Syndrome
Welcome,         Profile    Billing    Logout  
 2 Companies   2 Products   2 Products   0 Mechanisms of Action   0 Trials   12 News 
  • ||||||||||  Trial completion, Trial completion date:  Reverse Transcriptase Inhibitors in AGS (clinicaltrials.gov) -  Mar 5, 2019   
    P2,  N=11, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Jan 2018 --> Jun 2018
  • ||||||||||  Enrollment closed, Enrollment change:  Reverse Transcriptase Inhibitors in AGS (clinicaltrials.gov) -  Dec 21, 2017   
    P2,  N=11, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial completion date: Jan 2018 --> Jun 2018 Recruiting --> Active, not recruiting | N=24 --> 11
  • ||||||||||  Enrollment open, Trial primary completion date:  Reverse Transcriptase Inhibitors in AGS (clinicaltrials.gov) -  Oct 7, 2015   
    P2,  N=24, Recruiting, 
    Active, not recruiting --> Completed Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2017 --> Mar 2018
  • ||||||||||  Trial initiation date, Trial primary completion date:  Reverse Transcriptase Inhibitors in AGS (clinicaltrials.gov) -  Apr 15, 2015   
    P2,  N=24, Not yet recruiting, 
    Trial primary completion date: Jun 2015 --> Oct 2015 Initiation date: Mar 2015 --> Sep 2015 | Trial primary completion date: Aug 2017 --> Dec 2017
  • ||||||||||  New P2 trial:  Reverse Transcriptase Inhibitors in AGS (clinicaltrials.gov) -  Feb 18, 2015   
    P2,  N=24, Not yet recruiting,